Dr. Matthew Charles Brouns - NPI #1508869546

Hematologist & Oncologist located in Vancouver, WA

Washington Vancouver Hematology & Oncology Dr. Matthew Charles Brouns Information


Dr. Matthew Charles Brouns is a male Hematologist & Oncologist (taxonomy code 207RH0003X) located in Vancouver, Washington. Dr. Matthew Charles Brouns's NPI Number is #1508869546 and has been listed in the NPI registry for 13 years. Dr. Matthew Charles Brouns's practice location is listed as: 210 Se 136Th Ave Vancouver, WA 98684-6930 and can be reached via phone at (360) 944-9889.

Hematology & Oncology Taxonomy

The taxonomy code for Dr. Matthew Charles Brouns's main specialty, Hematology & Oncology, is 207RH0003X. An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.



Be the first to rate Dr. Brouns

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1508869546
 Phone (360) 944-9889
 Fax (360) 944-9686
210 Se 136Th Ave
Vancouver, WA 98684-6930
 Gender M
 Website Not provided
  • Hematology & Oncology (WA)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 12/22/2011
 Added 5/23/2005
 Viewed on 3/23/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.